• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和肿瘤性甲状腺组织中的表皮生长因子受体

Epidermal growth factor receptors in normal and neoplastic thyroid tissue.

作者信息

Duh Q Y, Gum E T, Gerend P L, Raper S E, Clark O H

出版信息

Surgery. 1985 Dec;98(6):1000-7.

PMID:3000011
Abstract

Epidermal growth factor (EGF) stimulates DNA synthesis and proliferation of thyroid cells in culture and may have an important role in the regulation of normal and neoplastic thyroid cell growth. We therefore studied paired normal and neoplastic thyroid tissue from eight patients for the presence of EGF receptors using a radioreceptor assay. 125I EGF binds to a particulate membrane fraction from both normal and neoplastic thyroid tissue with high affinity (dissociation constant ranged from 0.5 to 16.7 nmol/L). The binding is saturable, and maximal binding is achieved within 40 minutes at 37 degrees C and pH 7.5. This EGF binding is specific since it is competitively inhibited by unlabeled EGF but not by other hormones (thyrotropin, insulin, glucagon, and transferrin). The binding of EGF to thyroid neoplasms is higher than the binding to normal thyroid tissue (p less than 0.05). Thyroid tumors with a poorer prognosis appear to have higher EGF binding compared with adjacent normal thyroid tissue than have tumors with a better prognosis. EGF may have a role in the regulation of normal and neoplastic thyroid cell growth. Characterization of EGF receptors may help predict the clinical course of patients with malignant thyroid neoplasms.

摘要

表皮生长因子(EGF)可刺激培养的甲状腺细胞的DNA合成及增殖,在正常和肿瘤性甲状腺细胞生长的调节中可能发挥重要作用。因此,我们使用放射受体分析法研究了8例患者配对的正常和肿瘤性甲状腺组织中EGF受体的存在情况。125I EGF以高亲和力(解离常数范围为0.5至16.7 nmol/L)与正常和肿瘤性甲状腺组织的微粒膜部分结合。这种结合是可饱和的,在37℃和pH 7.5条件下40分钟内可达到最大结合。这种EGF结合具有特异性,因为它可被未标记的EGF竞争性抑制,但不受其他激素(促甲状腺激素、胰岛素、胰高血糖素和转铁蛋白)抑制。EGF与甲状腺肿瘤的结合高于与正常甲状腺组织的结合(p<0.05)。与预后较好的肿瘤相比,预后较差的甲状腺肿瘤与相邻正常甲状腺组织相比,似乎具有更高的EGF结合。EGF可能在正常和肿瘤性甲状腺细胞生长的调节中发挥作用。EGF受体的特性分析可能有助于预测甲状腺恶性肿瘤患者的临床病程。

相似文献

1
Epidermal growth factor receptors in normal and neoplastic thyroid tissue.正常和肿瘤性甲状腺组织中的表皮生长因子受体
Surgery. 1985 Dec;98(6):1000-7.
2
Specific epidermal growth factor receptors on porcine and human thyroid membranes.
Horm Metab Res. 1985 Nov;17(11):592-4. doi: 10.1055/s-2007-1013614.
3
Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growth factor and thyroid-stimulating hormone on their growth.培养的人甲状腺肿瘤细胞上的表皮生长因子受体以及表皮生长因子和促甲状腺激素对其生长的影响。
Cancer Res. 1988 Jul 1;48(13):3652-6.
4
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.乳腺肿瘤活检中表皮生长因子结合情况及其与雌激素受体和孕激素受体水平的关系。
Cancer Res. 1984 Aug;44(8):3448-53.
5
Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.人甲状腺肿瘤中促甲状腺激素受体-腺苷酸环化酶的功能
Cancer Res. 1981 Jun;41(6):2360-5.
6
Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.人类脑膜瘤及其他中枢神经系统肿瘤中表皮生长因子和转化生长因子α蛋白的检测
Surg Gynecol Obstet. 1993 Nov;177(5):488-96.
7
Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.甲状腺肿瘤中的促甲状腺激素结合与腺苷酸环化酶刺激作用
Surgery. 1981 Aug;90(2):252-61.
8
Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.表皮生长因子受体及表皮生长因子对长期组织培养中人类乳腺癌细胞生长的影响。
Cancer Res. 1982 Nov;42(11):4394-8.
9
Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.表皮生长因子受体的特性及其对培养的人乳腺癌细胞的作用。
Cancer Res. 1984 Aug;44(8):3442-7.
10
Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues.人甲状腺组织中表皮生长因子及表皮生长因子受体的核定位
Thyroid. 2001 Feb;11(2):137-45. doi: 10.1089/105072501300042785.

引用本文的文献

1
Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells.表皮生长因子受体激活可导致甲状腺癌细胞对仑伐替尼产生耐药性。
Cancer Sci. 2022 Sep;113(9):3193-3210. doi: 10.1111/cas.15465. Epub 2022 Jul 12.
2
Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.垂体腺苷酸环化酶激活肽(PACAP)及其1型受体(PAC1受体)在正常人体甲状腺及甲状腺乳头状癌中的表达
J Mol Neurosci. 2016 Oct;60(2):171-8. doi: 10.1007/s12031-016-0823-7. Epub 2016 Aug 26.
3
Medullary thyroid carcinoma: targeted therapies and future directions.
甲状腺髓样癌:靶向治疗及未来方向。
J Oncol. 2009;2009:183031. doi: 10.1155/2009/183031. Epub 2009 Dec 24.
4
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR.RET/PTC诱导的细胞生长部分是由表皮生长因子受体(EGFR)激活介导的:RET与EGFR之间分子和功能相互作用的证据。
Cancer Res. 2008 Jun 1;68(11):4183-91. doi: 10.1158/0008-5472.CAN-08-0413.
5
Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines.表皮生长因子受体靶向分子疗法在间变性甲状腺癌细胞系中的疗效
Br J Cancer. 2005 Mar 28;92(6):1110-6. doi: 10.1038/sj.bjc.6602461.
6
Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.非髓样甲状腺癌中细胞生长控制基因的表达模式:基础方面。
Rev Endocr Metab Disord. 2000 Apr;1(3):183-96. doi: 10.1023/a:1010079031162.
7
Predictors of thyroid tumor aggressiveness.甲状腺肿瘤侵袭性的预测因素。
West J Med. 1996 Sep;165(3):131-8.
8
Prognostic impact of EGF-receptor in papillary thyroid carcinoma.表皮生长因子受体在甲状腺乳头状癌中的预后影响
Br J Cancer. 1993 Oct;68(4):808-12. doi: 10.1038/bjc.1993.432.
9
Increased binding capacity of receptors for the epidermal growth factor in benign thyroid nodules and thyroid malignancies.良性甲状腺结节和甲状腺恶性肿瘤中表皮生长因子受体的结合能力增强。
Clin Investig. 1993 Nov;71(11):898-902. doi: 10.1007/BF00185600.
10
Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.转移性滤泡状甲状腺癌体外生长因子调控异常
Clin Exp Metastasis. 1994 Jul;12(4):315-23. doi: 10.1007/BF01753838.